FIELD: medicine. SUBSTANCE: invention relates to agents used for treatment of patients with hyperlipidemia and atherosclerosis and correction of blood rheological properties also. Invention proposes the use of cycvalon for treatment of these diseases. EFFECT: enhanced effectiveness of agent, minimal adverse effects in a long time using. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRONE LARVA HOMOGENATE AND LYOPHILIZATE ELICITING HYPOLIPIDEMIC AND HEPATOPROTECTIVE ACTIVITY | 2002 |
|
RU2239443C2 |
| ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
| AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
| METHOD OF ATHEROSCLEROSIS PROPHYLAXIS AND TREATMENT | 1995 |
|
RU2127113C1 |
| MEDICINAL-PROPHYLAXIS AGENT OF CHOLESTEROL-REGULATING ACTION AND A METHOD OF DISEASE TREATMENT CAUSED CHOLESTEROL METABOLISM DAMAGE IN ORGANISM | 1993 |
|
RU2043111C1 |
| METHOD FOR PREVENTING AND TREATING ATHEROSCLEROSIS | 1998 |
|
RU2148399C1 |
| METHOD OF PREPARING OF AGENT SHOWING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC EFFECT | 1991 |
|
RU2011383C1 |
